Skip to main content
. Author manuscript; available in PMC: 2023 Jul 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2022 Jul 1;90(Suppl 1):S90–S97. doi: 10.1097/QAI.0000000000002969

Table 1.

Participant Characteristics

Survey 1
N = 31
Survey 2
N = 42
Variable m (sd) n (%) m (sd) n (%)
Age 36.4 (11.6) 39.9 (12.6)
Race/Ethnicity
 Non-Latinx Black 20 (64.5) 23 (54.8)
 Latinx 2 (6.5) 9 (21.4)
 Other 9 (29.0) 8 (19.0)
 No Response 0 (0.0) 2 (4.8)
Current Gender Identity
 Cisgender Male 16 (51.6) 19 (45.2)
 Cisgender Female 12 (41.9) 22 (52.4)
 Transgender Female 1 (3.2) 0 (0.0)
 Nonbinary 1 (3.2) 1 (2.4)
Sexual Orientation
 Heterosexual 14 (45.2) 23 (54.8)
 LGBQ+ 17 (54.8) 19 (45.2)
Income Type
 Salaried 20 (64.5) 32 (76.2)
 Non-Salaried/Hourly 11 (35.5) 10 (23.8)
Length of Time at Agency
 0 – 2 Months 1 (3.2) 0 (0.0)
 3 – 5 Months 2 (6.5) 1 (2.4)
 6 – 11 Months 8 (25.8) 5 (11.9)
 12 Months or More 20 (64.5) 36 (85.7)
HIV Tester History
 Less than 1 Year 4 (12.9) 4 (9.5)
 1 – 2 Years 7 (22.6) 4 (9.5)
 3 – 4 Years 9 (29.0) 9 (21.4)
 5 – 7 Years 3 (9.7) 8 (19.0)
 8 – 10 Years 4 (12.9) 6 (14.3)
 11 – 15 Years 2 (6.5) 5 (11.9)
 15+ Years 2 (6.5) 6 (14.3)